Showing results (281-290 of 632) with videos related to
Sort By:
Pageof 64
European Review for Medical and Pharmacological Sciences|August 22, 2023
Treatment of fever and associated symptoms in the emergency department: which drug to choose?F Franceschi, A Saviano, A Carnicelli, et al.Arzneimittel-Forschung|November 1, 1986
Synthesis of guanylhydrazones derived from 3-pyridinol and evaluation of their effect on serum thromboxane B2 and prostaglandin E2 productionN Desideri, M L Stein, S Conti, et al.Mycopathologia|June 1, 1990
Production of yeast killer toxin in experimentally infected animalsL Polonelli, S Conti, M Gerloni, et al.Journal of Chemotherapy (Florence, Italy)|December 13, 2007
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 studyG Morace, M Drago, M M Scaltrito, et al.Dalton Transactions (Cambridge, England : 2003)|October 23, 2014
Sterically driven synthesis of ruthenium and ruthenium-silver N-heterocyclic carbene complexesC Cesari, S Conti, S Zacchini, et al.Current Molecular Medicine|June 28, 2005
Protective antifungal yeast killer toxin-like antibodiesW Magliani, S Conti, R Frazzi, et al.Nuclear Medicine and Biology|January 27, 2004
Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylationXiaoyuan Chen, Ryan Park, Anthony H Shahinian, et al.Acta Psychiatrica Scandinavica|April 1, 1997
Overcoming resistance to exposure in panic disorder with agoraphobiaG A Fava, G Savron, M Zielezny, et al.Journal of Neurochemistry|July 20, 2001
Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotectionR H Lipsky, K Xu, D Zhu, et al.Journal of Neural Transmission|January 1, 1985
Evaluation of hypothalamic dopaminergic function by neuropharmacologic means in aged womenD Cocchi, C Castoldi, S Locatelli, et al.Pageof 64